Watch-out database → Detailed ingredient information:
Restricted as per EC regulation 1223/2009?
– Identified as potential endocrine disruptor – Group A
|Date of update||Deadline||Content of update||Reference||Source||Obelis articles|
|10/11/20222||01/01/2025||There is a potential risk to human health arising from the use of Homosalate as a UV filter in cosmetic products in the concentration currently allowed. Therefore, the use of Homosalate should be restricted to face products (non-spray and pump spray products) only up to a maximum concentration of 7,34 %.||Commission Regulation (EU) 2022/2195||EC|
|N/A||No timeline applicable for now||According to the draft Regulation, the allowed level of Homosalate as as a UV filter will be lowered. Following the SCCS opinion, it will be allowed in face products with the exception of propellent spray roducts up to a maximum concentration of 7.34%. The Regulation is expected to be published by the end of 2022||Draft Regulation, WTO Notification||EC||Amendments to Annexes III and VI to the EU Cosmetics Regulation|
|02/12/2021||No timeline applicable for now||The SCCS concludes that Homosalate is safe as a UV-filter at concentrations up to 7.34% in face cream and pump spray||SCCS Scientific Advice 1638/21||SCCS|
|24-25/06/2021||No timeline applicable for now||Due to the potential endocrine disrupting properties of Homosalate, the SCCS has concluded that it is not safe when used as a UV-filter in cosmetic products at concentrations of up to 10%. SCCS considered it safe up to a maximum concentration of 0.5% in finished product. The use of Homosalate at the lower concentrations may have a bearing on efficacy as UV-filter, however this is outside the SCCS scope to assess the efficacy of cosmetic ingredients. TBC We strongly believe that new restrictions will be set out according to the above SCCS opinion.||SCCS Final Opinion 1622/20||SCCS|